logo-loader
NASDAQ:ADVM

Adverum Biotechnlogies Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$1.69 billion
Price
21.08 USD
Change
0.96%
52 weeks high
26.98
52 weeks low
4.96

In brief

Adverum Biotechnologies Inc (ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases.